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SUMMARY
Most cytochrome P450 (P450)-catalyzed reactions are believed
to involve an FeO31 intermediate as the actual oxygenating
species. However, studies on the mechanism of steroid aroma-
tization and subsequent model work have provided evidence
that a peroxo-iron form (formally FeO2
1) can be involved di-
rectly in some oxidations. The possible involvement of peroxo-
iron was considered in P450-catalyzed N-oxygenations, be-
cause there is precedent for the use of H2O2 and organic
peroxides in such reactions in the literature concerning syn-
thetic and flavin reactions. The approach used was to compare
P450 reactions involving the normal NADPH/NADPH-P450 re-
ductase/O2 system with those supported by the oxygen surro-
gates H2O2 (which can directly form FeO2
1 and subsequently
FeO31) and iodosylbenzene (which can form FeO31 but not
FeO2
1). Iodosylbenzene was effective in supporting rabbit
P450 1A2-catalyzed N,N-dimethyl-2-aminofluorene N-oxygen-
ation, human P450 3A4-catalyzed quinidine N-oxygenation, rat
P450 2B1-catalyzed oxidation of N-benzyl-(1-phenyl) cyclobu-
tylamine to the N-hydroxyamine and nitrone, and rat P450
2B1-catalyzed and rabbit P450 2B4-catalyzed N-oxygenation
of N,N-dimethylaniline (also N-demethylation). H2O2 also sup-
ported most of these reactions. A mutant of P450 2B4 with the
substitution of alanine for threonine at position 302 has been
shown to have decreased ability to catalyze reactions involving
the putative FeO31 but, presumably because of decreased
ability to protonate the FeO2
1 complex, to have enhanced
activity in oxidative deformylation reactions believed to involve
FeO2
1. This mutant showed both decreased N,N-dimethylani-
line N-demethylation and N-oxygenation activity. Although
some contribution of an FeO2
1 species to these reactions
cannot be ruled out, formation of product in the iodosylben-
zene-supported systems cannot be readily explained by an
obligatory FeO2
1 mechanism and the involvement of FeO31 is
concluded to be more likely.
P450 enzymes play important roles in the oxidation of
many drugs and other xenobiotic chemicals as well as many
compounds normally found in the body (1). (P450 is also
termed “heme thiolate protein” by the Enzyme Commission;
see Ref. 2 for nomenclature.) Some of the broad catalytic
specificity can be attributed to the presence of a large number
of individual proteins in this group, because more than 40
genes have been found in humans (2). However, it is also now
apparent that a single P450 can catalyze most of the types of
reactions found in the set. The current view is that the
chemistry used by the different P450s is relatively uniform,
with some exceptions, and that catalytic selectivity is pre-
dominantly a function of how the proteins bind potential
substrates and position atoms toward the reactive center
provided by the heme prosthetic group (1, 3).
One type of P450 reaction is heteroatom oxygenation,
which has been identified in the transfer of oxygen to the
atoms nitrogen, sulfur, phosphorus, and possibly iodine (4–
8). Such transfers seem precluded from many peroxidases
because of steric crowding (9, 10).N-Oxygenation, the subject
of this report, had been recognized as being catalyzed by the
flavoprotein termed “microsomal flavin-containing monooxy-
genase” (11) and was not considered to happen often in P450-
catalyzed reactions. There is a mechanistic rationale for this
(4). If amine oxidations proceed via single-electron oxidation
to form aminium radicals, then dealkylation should dominate
over oxygen “rebound” to the nitrogen due to facile deproto-
nation of a-hydrogens (4, 10). In some cases, a-deprotonation
is not possible andN-oxygenation is prominent. For instance,
with aryl and heterocyclic (primary) amines, there are no
a-hydrogens. Quinidine cannot lose protons, because of
Bredt’s Rule, and forms an N-oxide (12). The conversion of
azo compounds to azoxy can be rationalized in terms of ni-
trogen radical stability enhancement by the neighboring ni-
trogen lone pair (4). More recently, several examples of P450-
catalyzed N-oxygenation have been identified in which
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a-hydrogens are available but N-oxides are formed (13–16).
In all cases, however, N-oxygenation is accompanied by ex-
tensive N-dealkylation or products that can be rationalized
byN-dealkylation. The mechanism basis ofN-oxygenation is,
therefore, still considered to involve aminium radical forma-
tion and partial oxygen rebound, with the partitioning to
N-dealkylation being influenced by undescribed aspects of
protein structure (10).
Although most of the P450 reactions are rationalized in
terms of common chemistry involving the perferryl iron-oxy-
gen complex (FeO31) (Fig. 1), evidence for the involvement of
an alternative species has been obtained. The first two steps
of oxidative removal of C-methyl groups in the metabolism of
several steroids can be rationalized in terms of FeO31 chem-
istry, but the third step involves the oxidative removal of a
formyl group as HCO2H. The proposition that the FeO2
1
entity (FeOOO2 in Fig. 1) is involved in such a reaction was
first proposed by Akhtar (17). This proposal has been
strengthened by model studies from Cole and Robinson (18)
and by examples of such oxidative deformylation of mono-
cyclic and bicyclic model compounds by nonsteroidogenic
P450s (19–21).
The possible contribution of a FeO2
1 (peroxy-iron) inter-
mediate to the formation ofN-oxides and hydroxyamines also
can be considered.N-Oxides are prepared synthetically using
H2O2 and peracids (22, 23). Furthermore, the mechanism of
formation of N-oxides by microsomal flavin-containing mono-
oxygenase and biomimetic models involves a functionalized
hydroperoxide (24). However, these systems all yield only
N-oxides, without N-dealkylation.
Details of these two possible mechanisms, sequential elec-
tron transfer followed by oxygen rebound and direct oxygen-
ation by a ferric peroxide, are shown in Fig. 2, A and B,
respectively. The possibility that the iron-peroxy complex is
involved in N-oxygenation was raised in a previous report
from this laboratory (16), but the hypothesis was not sub-
jected to examination. Although direct proof for the role of an
FeO2
1 is unavailable in all cases, several indirect approaches
have been applied to test the possibility, including the use of
the oxygen surrogates H2O2 (potentially capable of forming
FeO2
1 5 Fe31 1 H2O2 2 2H
1) and PhIO (which can form
FeO31 but not FeO2
1) (19, 20) (Fig. 1). Another approach has
been the use of a P450 2B4 T302A mutant, which seems to
have attenuated ability to cleave FeO2
1 and enhanced pro-
ficiency to catalyze oxidative deformylation reactions (21).
Both approaches were used in the work on the mechanism of
P450 N-oxygenation reported here.
Materials and Methods
Chemicals. [methyl-14C]N,N-Dimethylaniline (10.1 mCi/mmol)
was purchased from Sigma Chemical (St. Louis, MO) and purified by
preparative HPLC before use (16). N,N-Dimethyl-2-aminofluorene
(16) and N-benzyl(1-phenyl)cyclobutylamine (15) were prepared as
described previously. The preparations of the respective oxides are
described in the same references. QuinidineN-oxide was prepared as
described previously (12): m.p. 145–152°, lit m.p. 148–150° (12); fast
atom bombardment mass spectrometry, m/z 341 (MH1, 100% rela-
tive abundance); UV (H2O) lmax 235, 280, 322, 334 nm. PhIO was
prepared by hydrolysis of the diacetate (25). H2O2 (30% solution) was
purchased from Fisher Scientific (Pittsburgh, PA).
Enzymes. P450 2B1 was purified from livers of phenobarbital-
treated rats as described elsewhere (26). Modified constructs of hu-
man P450 1A2 (27) and 3A4 (28) were expressed in Escherichia coli
and purified as described previously. A modified construct of rabbit
P450 2B4, devoid of normal residues 2–27, and the T302A mutant
(change of threonine to alanine at position 302) were expressed in E.
coli as glutathione transferase proteins, purified by glutathione af-
finity chromatography, cleaved with thrombin, and purified as de-
scribed previously (21, 29). Fp (30) and cytochrome b5 (31) were
purified from livers of phenobarbital-treated rabbits essentially as
described.
Assays. Unless indicated otherwise in the tables (i.e., P450 3A4),
all assays were performed in 0.10 M potassium phosphate buffer, pH
7.7, which contained 30 mM L-a-dilauroyl-sn-glycero-3-phosphocho-
line. The NADPH-dependent systems included the indicated amount
of Fp plus an NADPH-generating system consisting of (final concen-
trations of) 0.5 mM NADP1, 10 mM glucose 6-phosphate, and 1 IU of
yeast glucose 6-phosphate dehydrogenase/ml, plus catalase (0.18 mM)
to quench any generated H2O2 (32). NADPH-dependent incubations
were performed at 37° for 15 min. The H2O2-dependent incubations
included 2.0 mMH2O2 (20) and were performed at 37° for 10 min. The
PhIO-dependent incubations were performed at 23° for 30 sec (20,
33). Reactions were quenched by the addition of 2 volumes of CH2Cl2
for extraction. Control incubations were performed using P450s with
Fig. 1. General mechanism of P450 catalysis.
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cofactors (e.g., NADPH, H2O2, or PhIO) and with the cofactors in the
absence of P450.
The analyses of products all were performed by HPLC as described
previously, using detection by UV in the case of the N-benzyl(1-
phenyl)cyclobutylamine products (15), fluorescence with quinidine
N-oxide (12), and radioactivity in the case of the N,N-dimethylani-
line products (16). The UV absorbance of 2-N,N-dimethylflourene
N-oxide is appreciable compared with monocyclic analogs (16), and
this compound was assayed directly by HPLC (A295) rather than with
the previously described isolation/reduction/HPLC method (16). Ex-
ternal standards were used for HPLC. P450 concentrations were
determined from Fe21zCO versus Fe21 spectra using the method of
Omura and Sato (34).
Results and Discussion
Rationale. The extent of product formation was compared
in P450 systems supported by NADPH, H2O2, and PhIO to
evaluate the role of the perferryl P450 intermediate, FeO31
(Figs. 1 and 2). In previous studies with model aldehydes, it
was concluded that reactions involved the FeO2
1 intermedi-
ate, instead of FeO31, if reactions were supported more ef-
fectively by H2O2 than NADPH and if PhIO was not able to
support reactions (20). If the FeO31 form is involved, H2O2
can still support the reaction. However, FeO2
1-dependent
reactions should not be supported by PhIO. This general
approach was applied to four known N-oxygenation reactions
catalyzed by four different P450s.
The choice of concentrations of cofactors (i.e., H2O2, PhIO)
was based on literature precedents (20, 33). The oxygen sur-
rogates are destructive to P450; PhIO is more so than H2O2
(32, 33, 35). The choices of time and concentration are based
on the literature and preliminary trials with P450 2B1 de-
pendent N,N-dimethylaniline N-oxygenation. On the basis of
the previous work in this area (20), the times and cofactor
concentrations should favor greater linearity of product for-
mation in the H2O2-dependent system compared with the
PhIO-dependent system. However, time course experiments
were not performed in all cases; thus, the results are ex-
pressed as total products rather than rates.
N,N-Dimethyl-2-aminofluorene N-Oxygenation. This
reaction is catalyzed by P450 2B1, with an appreciable ratio
of N-oxygenation/N-demethylation (16). NADPH-dependent
N-oxygenation was also demonstrated with rabbit P450 1A2
(Table 1). The reaction was also supported by PhIO; the level
of N-oxide formation seen with H2O2 was near the limit of
detection.
Quinidine N-Oxygenation. Quinidine is oxidized in hu-
man liver microsomes, primarily by P450 3A4, to the 39-
hydroxy and N-oxide products (12). The amount of N-oxide
formed with PhIO was as high as in the case of NADPH
(Table 2). However, the amount formed in the presence of
H2O2 was considerably higher than either the NADPH- or
PhIO-based reaction.
N-Benzyl(1-phenyl)cyclobutylamine Oxidation. This
substrate had been used previously in studies involving
mechanism-based inactivation of P450 2B1 and ring expan-
sion, invoking an aminium radical intermediate (15). Sur-
prisingly, the substrate was converted to a stable nitrone as
one of the major products, apparently via an N-hydroxy-
amine. The nitrone could be formed from the N-hydroxy-
amine by oxygenation on nitrogen or alternatively by another
mechanism involving initial oxidation of the nitrogen (1-
electron oxidation) and abstraction of the a-hydrogen (with
or without hydroxylation at the a-hydrogen).
Both of these products, the N-hydroxyamine and the ni-
trone, were seen in all three systems (NADPH, H2O2, PhIO)
(Table 3), with the N-hydroxyamine favored in the case of
NADPH and the nitrone in the case of H2O2.
N,N-Dimethylaniline N-Oxygenation. This substrate
was selected because of historic interest in the reaction (36,
37) and the opportunity to examine partitioning between
Fig. 2. Possible mechanisms of N-oxygenation by P450. A, Sequential electron transfer followed by oxygen rebound. B, direct oxygenation by
a ferric peroxide.
TABLE 1
N-Oxygenation of N,N-dimethyl-2-aminofluorene by rabbit
P450 1A2
The experiments were done with 5.3 nmol of rabbit P450 1A2 and, in the NADPH
system, 7.5 nmol of Fp in a final volume of 1.0 ml. The concentration of N,N-
dimethyl-2-aminofluorene was 50 mM. Values are means of triplicate experi-
ments 6 standard deviation.
System N-Oxide formed
nmol
NADPH 1.6 6 0.6
H2O2 0.08 6 0.08
PhIO 0.29 6 0.06
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N-oxygenation and N-oxygenation reactions at the same site
(16). The amount of N-oxygenation is low but finite (16), and
radioactivity assays provide the only sensitive approach to
examining rates, except for the isolation/reduction/rechro-
matography approach used previously (10). P450 2B1 had
been used previously in assays (16). A rather homologous
rabbit protein, 2B4, was examined because of its expected
catalytic similarity and because the T302A mutant was
available and had been used in studies on the role of the
FeO2
1 in the decarboxylation of model aldehydes (21).
Thr302, apparently analogous to Thr268 of P450 101
(P450cam), seems to be involved in the heterolytic cleavage of
the OOO bond (38). The mutation was shown to facilitate the
reaction believed to involve an FeO2
1 entity but to attenuate
reactions in which cleavage to FeO31 is required (21).
P450 2B1-catalyzed N-demethylation was supported by
NADPH and by H2O2 or PhIO, although not so effectively
(Table 4). The differences were not so great in the case of
P450 2B4, primarily because the NADPH-dependent reac-
tion was slower. The three N-demethylation reactions, sup-
ported by the different cofactors, were all slower with the
T302A mutant.
N-oxygenation by P450s 2B1 and 2B4 occurred to similar
extents in the reactions supported by different cofactors (Ta-
ble 4). With the T302A mutant, all reactions were attenu-
ated, particularly the H2O2-dependent reaction. The de-
creased catalytic activity seen in the reactions supported by
the oxygen surrogates may be the result of decreased stabil-
ity of the T302A mutant to these oxidants. This aspect of the
T302A mutants has not been examined previously (21).
The conclusions regarding the work with N,N-dimethyla-
niline reactions are that the mutation of Thr302 seems to
decrease both N-demethylation and N-oxygenation. In all
cases, a substantial amount of PhIO-dependent N-oxygen-
ation was observed.
Conclusions. The potential similarity of the oxygenation
of amines by P450s to reactions that occur with peracids and
hydroperoxides (22, 23) and the flavin hydroperoxide inter-
mediate of the flavin-containing monooxygenase (11) sug-
gested that P450 might use a recently discovered mechanism
involving the FeO2
1 entity. However, examination of four
different N-oxygenations with four different P450s does not
provide any evidence for such a view.
The results show that the PhIO-dependent system formed
products, as did the H2O2-dependent system (Tables 1–4). It
is also accepted that the FeO2
1 species, formed by the addi-
tion of H2O2, breaks down to give the FeO
31 species. The
results obtained from these experiments, which are designed
to distinguish between FeO2
1 and FeO31, seem more consis-
tent with the key role of FeO31 as the active species account-
able for product formation in this system rather than FeO21.
Further, mutation of P450 2B4 Thr302 to alanine attenuated
the NADPH-dependent N-oxygenation and N-dealkylation of
N,N-dimethylaniline, in contrast to what would have been
expected if the FeO2
1 entity had a dominant role in oxygen-
ation. These results can be rationalized by the limited ability
of a nucleophilic intermediate (FeO2
1 5 Fe21OOOO2) to
attack a nucleophilic site, whether or not it is protonated
(Fig. 2B).
An N-oxygenation mechanism is preferred that involves
1-electron oxidation of the nitrogen atom as a first step and
subsequent oxygen rebound (10, 39), as proposed for P450
sulfur oxygenations (6, 40). Details of the reaction remain
unknown, particularly whether a FeO2
1/aminium radical
pair undergoes additional electron transfer before rebound
(10). However, the conclusion is reached here that the FeO31
entity is an inherent part of the mechanism of N-oxygenation
by many P450s.
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TABLE 2
N-Oxygenation of quinidine by human P450 3A4
Experiments were performed with 0.65 nmol of P450 3A4 and, in the case of
NADPH plus Fp incubations, 1.3 nmol of Fp, and 0.65 nmol of cytochrome b5. All
incubates included 0.50 ml of 50 mM potassium HEPES buffer, pH 7.7, containing
a mixture of a 1:1:1 (w/w/w) mixture of L-a-dilauroyl-sn-glycero-3-phosphocho-
line, L-a-dioleyl-sn-glycero-3-phosphocholine, and bovine brain phosphatidylser-
ine (20 mg/ml), 0.50 mM sodium cholate, 30 mM MgCl2, and 200 mM quinidine (28).
Values are means of triplicate experiments 6 standard deviation.
System N-Oxide formed
nmol
NADPH 0.33 6 0.10
H2O2 2.14 6 0.17
PhIO 0.32 6 0.02
TABLE 3
Oxygenation of N-benzyl-(1-phenyl)cyclobutylamine by rat
P450 2B1
Incubations included 2.2 nmol of rat P450 2B1 and, in the NADPH system, 3.0
nmol Fp. The final volume was 1.0 ml in all cases, and the substrate concentration
was 1.0 mM. Values are mean of triplicate experiments 6 standard deviation.
System N-Hydroxyamine formed Nitrone formed
pmol nmol
NADPH 48 6 14 1.9 6 0.1
H2O2 14 6 2 3.0 6 0.2
PhIO 13 6 5 0.8 6 0.2
TABLE 4
N-oxygenation and N-demethylation of N,N-dimethylaniline by rat
P450 2B1 and rabbit P450 2B4 derivatives
The system contained either 1.0 nmol of P450 2B1 plus 1.6 nmol of Fp or 0.50
nmol of P450 2B4 (or P450 2B4 T302A) plus 0.80 nmol of Fp, in a volume of 0.50
ml (Fp added only in the NADPH system). Results are expressed as means of




2B1 2B4 2B4, T302A
pmol/nmol P450
N-Methylaniline
NADPH, Fp 240 96 6 21 48 6 8
H2O2 21 47 6 5 5 6 1
PhIO 21 25 6 1 8 6 5
N-Oxide
NADPH, Fp 110 6 35 180 6 15 26 6 6
H2O2 130 6 60 180 6 60 3 6 3
PhIO 130 140 6 15 67 6 42
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